German specialty chemicals company making additives, catalysts, animal nutrition and specialty materials.
German specialty chemicals company making additives, catalysts, animal nutrition and specialty materials.
Sells specialty ingredients such as additives and animal-feed amino acids, where Evonik's product is a small part of the customer's cost but matters to the final product. Earnings depend on the spread above raw-material and energy costs. RAG-Stiftung, a foundation set up to fund the legacy costs of German coal mining, is the largest shareholder.
Moat: narrow (process know-how, IP / patents, scale). Leading positions in niche specialty chemical markets like methionine (animal nutrition) and silica.
Headquarters: Essen, Germany · Founded: 2007 · Employees: 31,053
Size Evonik Industries (EVK.DE) is a Germany Materials company (Chemicals: Major Diversified) with a market value of $11.0B, the 50th largest of 205 Germany companies the cockpit tracks. Shares closed at €21.12 on 6 Nov 2026.
Performance Over six months the shares gained 18.8%, against -4.3% for the median peer and +2.6% for the Germany market (cap-weighted) — 5th highest of 21 in its peer set.
Growth Revenue grew 2.0% over the last twelve months (peer median +4.8%); the operating margin is 9.9% (peer median 8.4%).
Valuation It trades at 12.0× forward earnings against a peer median of 15.3× (4th cheapest of 20).
Price implies For today's price to make sense, revenue must grow about -6% a year for seven years (Req g). Recent delivered growth is +3%, so the hurdle is -9 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 2.9 points above its cost of capital (5.6% WACC).
Credit Evonik Industries has 5 bonds outstanding ($2.70B), rated BBB+ by the agencies and trading like AA+ at a weighted spread of 30 bp.
Next results Next results expected around 4 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | €14.5B | €14.1B | €15.2B | €15.3B | €18.5B |
| Revenue growth | — | -7% | -1% | -17% | — |
| Gross profit | €3.38B | €3.46B | €3.90B | €3.39B | €4.27B |
| EBITDA | €2.43B | €1.85B | €2.07B | €1.71B | €2.29B |
| Net income | €174M | €265M | €222M | -€465M | €539M |
| Free cash flow | €902M | €632M | €801M | €734M | €728M |
| Capital expenditure | €798M | €748M | €840M | €793M | €865M |
| Total debt | €4.34B | €3.87B | €3.78B | €4.25B | €4.23B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Evonik Industries EVK.DE | $11.0B | +19% | +2% | 10% | 12.0× | -6.2% |
| Basf BAS.DE | $52.6B | +2% | -4% | 7% | 16.8× | 5.7% |
| Lanxess LXS.DE | $1.27B | -30% | -10% | -1% | n/a | 17.9% |
| Wacker Chemie WCH.DE | $4.42B | -24% | -5% | -1% | 33.0× | n/a |
| Clariant CLN.SW | $4.32B | +46% | -7% | 10% | 16.0× | -3.4% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | EVK.DE | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +0.7% | -3.5% | 8th highest of 21 |
| 6-month return | +18.8% | -4.3% | 5th highest of 21 |
| Distance from 52-week high | -3.3% | -24.0% | highest of 21 |
| Revenue growth (TTM) | +2.0% | +4.8% | 8th lowest of 21 |
| Operating margin | 9.9% | 8.4% | 10th highest of 21 |
| Forward P/E | 12.0× | 15.3× | 4th cheapest of 20 |
| Growth the price implies (Req g, 7 yrs) | -6.2% | 9.9% | least demanding of 16 |
| Growth delivered (Del g) | +2.9% | +6.6% | 7th lowest of 16 |
| Hurdle (Req g minus delivered) | -9.1 pp | +4.9 pp | 3rd least demanding of 16 |
| ROIC minus cost of capital | +2.9 pp | -1.8 pp | 7th highest of 21 |
| EV / EBITDA | 5.6× | 10.7× | 3rd cheapest of 13 |
| Net debt / EBITDA | 1.6× | 1.8× | 6th least indebted of 14 |
| Bond spread | 30 bp | 126 bp | tightest of 8 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Evonik Industries EVK.DE | Germany | $11.0B | +19% | +2% | 10% | 12.0× | -6.2% | +2.9% |
| Sasol Limited Sponsored ADR SSL | United States | $10.3B | +14% | +18% | 22% | 4.8× | n/a | n/a |
| Peric Special Gases 688146.SS | China | $9.58B | +102% | +75% | 19% | 67.1× | 50.8% | +13.1% |
| Solstice Advanced Materials SOLS | United States | $9.22B | -26% | +3% | 17% | 17.8× | 0.3% | +2.7% |
| Mitsubishi Chemical 4188.T | Japan | $8.65B | +10% | -8% | 8% | 8.9× | -0.5% | +2.6% |
| Element Solutions ESI | United States | $7.61B | -29% | +40% | 14% | 15.0× | 16.6% | +6.6% |
| Ecopro 086520.KS | South Korea | $6.55B | -57% | +11% | 9% | 31.5× | n/a | n/a |
| DuPont DD | United States | $19.4B | -1% | -43% | 14% | 18.3× | 14.7% | -13.7% |
| Tokyo Ohka Kogyo 4186.T | Japan | $5.03B | -30% | +22% | 21% | 17.8× | 19.9% | +15.1% |
| Arkema AKE.PA | France | $4.96B | -9% | -6% | 5% | 13.7× | 12.5% | +2.8% |
| Kingfa Sci. & Tech 600143.SS | China | $4.96B | -28% | -1% | 3% | 24.6× | -1.2% | +13.3% |
| Perimeter Solutions PRM | United States | $4.83B | -7% | +24% | -51% | 18.3× | 36.6% | +14.0% |
| Wacker Chemie WCH.DE | Germany | $4.42B | -24% | -5% | -1% | 33.0× | n/a | n/a |
| Hubei Xingfa Chemicals 600141.SS | China | $4.19B | -27% | +4% | 8% | 15.3× | n/a | n/a |
| Avient AVNT | United States | $4.17B | +23% | +5% | 11% | 13.0× | 9.9% | +0.1% |
| Mitsui Chemicals 4183.T | Japan | $4.08B | -9% | -3% | 6% | 10.7× | 1.9% | +6.6% |
| Johnson Matthey JMAT.L | United Kingdom | $4.01B | +14% | +8% | 3% | 13.3× | 9.6% | -4.0% |
| Kuraray 3405.T | Japan | $3.52B | +14% | +3% | 7% | 15.0× | -0.2% | +8.3% |
| Sika SIKA.SW | Switzerland | $36.4B | +32% | -4% | 14% | 24.9× | 10.7% | +7.3% |
| Grandit 688549.SS | China | $2.89B | +36% | +40% | -1% | n/a | n/a | n/a |
| CES Energy Solutions CEU.TO | Canada | $2.82B | +4% | +11% | 10% | 14.1× | 9.2% | +22.9% |
Evonik Industries has 5 bonds outstanding with $2.70B face value. The agencies rate it BBB+; its bonds trade like AA+. Weighted yield 3.27%, a spread of 30 bp over government bonds.